Programmed lymphocytes death in pancreatic cancer patients

Central-European Journal of Immunology

Volumn 35, Issue 2, 2010, Pages 84-89

  Kȩdziora, Sylwia ^a   Słotwiński, Robert ^a,b   Olszewski, Waldemar L ^b   Słodkowski, Maciej ^a   Lech, Gustaw ^a   Zaleska, Marzanna ^b   Włuka, Anna ^b   Domaszewska, Anna ^b   Krasnodȩbski, Ireneusz W ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Apoptosis; Immune dysfunction; Pancreatic cancer

Indexed keywords

NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN CAS3; PROTEIN CAS9; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE; MALE; PANCREAS CANCER; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 77952306935     PISSN: 14263912     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Annual Reports on Vital Statistics 1951-2002. Government Publications Office, Dublin, 2005.
2. Cancer Services in Ireland: A National strategy. Government Publications Office, Dublin 2005.
3. Conlon KC, Klimstra DS, Brennan MF (1996): Long-term survival after curative resection for pancrearic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann Surg 233: 273-279.
4. Schafer M, Mullhaupt B, Clavien PA (2002): Evidence-based pancreatic head resection for pancreatic cancer and chronic pancreatitis. Ann Surg 236: 137-148.
5. Trede M, Richter A., Wendl K (2001): Personal observations, opinions, and approaches to cancer of the pancreas and the periampullary area. Surg Clin North Am 81: 595-610.
6. Carpelan-Holmstrom M, Nordiing S, Pukkala E et al. (2005): Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry. Gut 54: 385-387.
7. Wagner M, Redaelli C, Lietz M et al. (2004): Curative resection in the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg 91: 586-594. (Pubitemid 38624667)
8. Buchler MW, Wagner M, Schmidt BM et al. (2003): Changes in morbidity after pancreatic resection: toward the end of completion pancreatectomy. Arch Surg 138: 1310-1314.
9. Capussotti L, Massucco P, Ribero D et al. (2003): Extended lymphadenectomy and vein resection for pancreatic head cancer: outcomes and implications for therapy. Arch Surg 138: 1316-1322.
10. Richter A, Niedergethmann M, Sturm JW et al. (2003): Long-term results of partial pancreatoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience. World J Surg 27: 324-329. (Pubitemid 36920145)
11. Seiler CA, Wagner M, Bachmann T et al. (2005): Randomized clinical trial of pylorus-preserving duodenopancreatoduodenectomy versus classical Whipple resection - long term results. Br J Surg 92: 547-556. (Pubitemid 40685648)
12. Tran KT, Smeek HG, van Eijck CH et al. (2004): Pylorus preserving pancreatoduodenectomy versus standard Whipple procedure: a prospective, randomized, multicenter analysis of 170 patients with pancreaticand periampullary tumors. Ann Surg 240: 738-745.
13. von Bernstorff W, Voss M, Freichel S et al. (2001): Systemic and local immunosuppression in pancreatic cancer patients. Clin Cancer Res 7: 925-932.
14. Poch B, Lotspeich E, Ramadani M et al. (2007): Systemic immune dysfunction in pancreatic cancer patients. Langenbecks Arch Surg 392: 353-358. (Pubitemid 46675798)
15. Greco E, Fogar P, Mazzon C et al. (2007): Pancreatic cancer pulls down lymphocyte migration. JOP 8: 685-686.
16. Igney FH, Krammer PH (2002): Death and anti-death: Tumourresistance to apoptosis. Nature Rev Cancer 2: 277-288.
17. Ekshyyan O, Aw TY (2004): Apoptosis: a key in neurodegenerative disorders. Curr Neurovasc Res 1: 355-371.
18. Vermeulen K, van Bocksteale DR, Berneman ZN (2005): Apoptosis: mechanisms and relevance in cancer. Ann Hematol 84: 627-639.
19. Mahoney JA, Rosen A (2005): Apoptosis and autoimmunity. Curr Opin Immunol 17: 581-588.
20. Boyum A (1968): Separation of leucocytes from blood and bone marrow. Scand J Clin Lab Incest 21, Suppl. 97.
21. Lowe SW, Lin AW (2000): Apoptosis in cancer. Carcinogenesis 21: 485-495.
22. Walczak H, Krammer PH (2000): The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems. Experimental Cell Res 256: 58-66. (Pubitemid 30211167)
23. Loeffler M, Kroemer G (2000): The mitochondrion in cell death control: certainties and incognita. Experimental Cell Res 256: 19-26. (Pubitemid 30211162)
24. Nagata S (2000): Apoptotic DNA fragmentation. Experimental Cell Res 256: 12-18.
25. Vaux DL, Korsmeyer SJ (1999): Cell death in development. Cell 96: 245-254.
26. Wei MC, Zong W-X, Cheng EH-Y et al. (2001): Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292: 727-730.
27. Marzo I, Perez-Galan P, Giraldo P et al. (2001): Cladribine induces apoptosis in human leukaemia cells by caspase-dependent and -independent pathways acting on mitochondria. Biochem J 59: 537-546. (Pubitemid 33063377)
28. Green DR, Reed JC (1998): Mitochondria and apoptosis. Science 281: 1322-1326.
29. Hsu YT, Wolter KG, Youle RJ (1997): Cytosol-to-membrane redistribution of Bax and Bclxl during apoptosis. Proc Natl Acad Sci U S A 94: 3668-3672. (Pubitemid 27180430)
30. Klatka J, Rolinski J, Kupisz K et al. (1999): Expression of bcl-2 protein in lymphocytes of patients with laryngeal carcinoma. Eur Arch Otorhinolaryngol 256: 299-302. (Pubitemid 29376268)
31. Tenuzzo B, Vergallo C, Dini L (2009): Effect of 6mT static magnetic field on the bcl-2, bax, p53 and hsp70 expression in freshly isolated and in vitro aged human lymphocytes. Tissue Cell 41: 169-179.
32. Sharief MK, Douglas M, Noori M, Semra YK. The expression of pro- and anti-apoptosis Bcl-2 family proteins in lymphocytes from patients with multiple sclerosis. J Neuroimmunol 2002; 125:155-162.
33. Bei E, Salpeas V, Pappa D (2009): Phosphorylation status of glucocorticoid receptor, heat shock protein 70, cytochrome c and Bax in lymphocytes of euthymic, depressed and manic bipolar patients. Psychoneuroendocrinology 34: 1162-1175.
34. Locksley RM, Killeen N, Lenardo MJ (2001): The TNF and TNF Receptor Superfamilies: Integrating Mammalian Biology. Cell 104: 487-501.
35. Ankersmit HJ, Moser B, Zuckermann A et al. (2002): Activation-induced T cell death, and aberrant T cell activation via TNFR1 and CD95-CD95 ligand pathway in stable cardiac transplant recipients. Clin Exp Immunol 128: 175-180.
36. de Oliveira Pinto LM, Garcia S, Lecoeur H et al. (2002): Increased sensitivity of T lymphocytes to tumor necrosis factor receptor 1 (TNFR1) - and TNFR2-mediated apoptosis in HIV infection: relation to expression of Bcl-2 and active caspase-8 and caspase-3. Blood 99: 1666-1675.
37. Cryns V, Yuan J (1998): Proteases to die for. Genes Dev 12: 1551-1570.
38. Kothakota S, Azuma T, Reinhard C et al. (1997): Caspase 3 - generated fragment of gelsolin: effector of morphological change in apoptosis. Science 278: 294-298.
39. Takahashi A, Alnemri ES, Lazebnik YA et al. (1996): Cleavage of lamin A by Mch2? but not CPP32: Multiple interleukin 1-β converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis. Proc Natl Acad Sci USA 93: 8395-8400.
40. Vendrame F, Santangelo C, Misasi R et al. (2005): Defective lymphocyte caspase-3 expression in type 1 diabetes mellitus. Eur J Endocrinol 152: 119-125.
41. Zaunders J, Moutouh-De Parceval L, Kitada S et al. (2001): Apoptosis of CD4+ and CD8+ T lymphocytes in primary HIV-1 infection is associated with proliferation, increased Bax: Bcl-2 ratio and caspase activation. Program Abstr 8th Conf Retrovir Oppor Infect Conf Retrovir Oppor Infect 8th 2001 Chic Ill. 8: 275 (abstract no. 761).
42. Tacconi S, Perri R, Balestrieri E et al. (2004): Increased caspase activation in peripheral blood mononuclear cells of patients with Alzheimer's disease. Exp Neurol 190: 254-262.
43. Takahashi A, Kono K, Amemiya H et al. (2001): Elevated caspase-3 activity in peripheral blood T cells coexists with increased degree of T-cell apoptosis and down-regulation of TCR zeta molecules in patients with gastric cancer. Clin Cancer Res 7: 74-80.
44. Delogu G, Famularo G, Tellan G et al. (2008): Lymphocyte apoptosis, caspase activation and inflammatory response in septic shock. Infection 36: 485-487.
45. Peralta-Leal A, Rodríguez MI, Oliver FJ. (2008): Poly(ADPribose) polymerase-1 (PARP-1) in carcinogenesis: potenstial role of PARP inhibitors in cancer treatment. Clin Trans Oncol 10: 318-323.
46. Rajaee-Behbahari N, Schmezer P, Ramroth H et al. (2002): Reduced poly(ADP-ribosyl)ation in lymphocytes of laryngeal cancer patients: results of a case control study. Int J Cancer 98: 780-784.
47. von Meyenfeldt M (2005): Cancer-associated malnutrition: an introduction. Eur J Oncol Nurs 9: S35-S38.
48. Ziegler TR, Evans ME, Fernández-Estívariz C, Jones DP. (2003): Trophic and cytoprotective nutrition for intestinal adaptation, mucosal repair, and barrier function. Annu Rev Nutr 23: 229-261.